These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
235 related items for PubMed ID: 17893038
1. Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. Santilli F, Bucciarelli L, Noto D, Cefalù AB, Davì V, Ferrante E, Pettinella C, Averna MR, Ciabattoni G, Davì G. Free Radic Biol Med; 2007 Nov 01; 43(9):1255-62. PubMed ID: 17893038 [Abstract] [Full Text] [Related]
2. The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin. Murrow JR, Sher S, Ali S, Uphoff I, Patel R, Porkert M, Le NA, Jones D, Quyyumi AA. J Clin Lipidol; 2012 Nov 01; 6(1):42-9. PubMed ID: 22264573 [Abstract] [Full Text] [Related]
3. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP. Am J Geriatr Pharmacother; 2007 Sep 01; 5(3):185-94. PubMed ID: 17996658 [Abstract] [Full Text] [Related]
4. Association of the Gly82Ser polymorphism in the receptor for advanced glycation end products (RAGE) gene with circulating levels of soluble RAGE and inflammatory markers in nondiabetic and nonobese Koreans. Jang Y, Kim JY, Kang SM, Kim JS, Chae JS, Kim OY, Koh SJ, Lee HC, Ahn CW, Song YD, Lee JH. Metabolism; 2007 Feb 01; 56(2):199-205. PubMed ID: 17224333 [Abstract] [Full Text] [Related]
5. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response. Boodhwani M, Nakai Y, Voisine P, Feng J, Li J, Mieno S, Ramlawi B, Bianchi C, Laham R, Sellke FW. Circulation; 2006 Jul 04; 114(1 Suppl):I402-8. PubMed ID: 16820608 [Abstract] [Full Text] [Related]
12. Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatment. Stulc T, Malbohan I, Malík J, Fialová L, Soukupová J, Ceska R. Am Heart J; 2003 Dec 04; 146(6):E21. PubMed ID: 14661010 [Abstract] [Full Text] [Related]
15. Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. Emanuele E, D'Angelo A, Tomaino C, Binetti G, Ghidoni R, Politi P, Bernardi L, Maletta R, Bruni AC, Geroldi D. Arch Neurol; 2005 Nov 04; 62(11):1734-6. PubMed ID: 16286548 [Abstract] [Full Text] [Related]
16. Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. Ferrante E, Vazzana N, Santilli F, Di Cicco M, Lauriti C, Di Battista L, Ciabattoni G, Di Matteo L, Davì G. Free Radic Biol Med; 2010 Sep 01; 49(5):857-64. PubMed ID: 20541603 [Abstract] [Full Text] [Related]
18. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S. Clin Ther; 2008 Jun 01; 30(6):1089-101. PubMed ID: 18640465 [Abstract] [Full Text] [Related]
19. Statin face-off. Surprises from the first head-to-head comparison. Gupta S. Time; 2003 Nov 24; 162(21):83. PubMed ID: 14666603 [No Abstract] [Full Text] [Related]